Western blotting indicated that only the protein level decreased in OCPs treated by JNK antagonist, but not p38 MAPK antagonist (Fig. 4G, H), indicated that JNK pathway was the upstream of c-Jun in OCPs after treatment of lactate in CRC microenvironment. This evidence concerns the gene JUN and colorectal carcinoma.